73 completed. 73 Phase 3, 28 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 73 | Completed 73 |
| Phase 2 | 28 | Completed 28 |
Follow Metabolic Syndrome: new trials by email Literature Review of Metabolic Syndrome trials Research Report on Metabolic Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide 2.4 mg in Patients With Poor Weight-loss Semaglutide 3 mg, Placebo - Obesity, Diabetes | Phase 3 | Completed | University College, London | 70 | 2022-11-01 | 2026-10-26 |
| Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir generic single tablet TAF/FTC/DTG - HIV | Phase 3 | Completed | The HIV Netherlands Australia Thailand Research Collaboration | 170 | 2019-05-01 | 2024-02-28 |
| Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Amla, Placebo - Metabolic Syndrome | Phase 2 / Phase 3 | Completed | University of Guadalajara | 28 | 2019-04-01 | 2022-11-08 |
| Berberine as Adjuvant Treatment for Schizophrenia Patients Berberine, Placebos, Antipsychotic Agents - Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders | Phase 2 / Phase 3 | Completed | The University of Hong Kong | 113 | 2018-04-25 | 2021-01-22 |
| Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination Simvastatin 10mg, sofosbuvir plus daclatasvir - Chronic Hepatitis c, Metabolic Syndrome | Phase 2 / Phase 3 | Completed | Ain Shams University | 100 | 2017-12-01 | 2018-09-20 |
| Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome Metformin, Placebo, Low Intensity Exercise - Metabolic Syndrome | Phase 2 / Phase 3 | Completed | Rutgers University | 91 | 2017-08-07 | 2025-09-22 |
| Green Coffee Extract and Metabolic Syndrome green coffee extract, placebo - Metabolic Syndrome | Phase 2 / Phase 3 | Completed | National Nutrition and Food Technology Institute | 43 | 2016-12-01 | 2017-08-28 |
| Study of Testosterone vs Placebo in Testicular Cancer Survivors Testosterone, Placebos - Metabolic Syndrome, Testicular Cancer | Phase 2 / Phase 3 | Completed | Mikkel Bandak | 69 | 2016-11-01 | 2020-03-06 |
| Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome Anakinra, Sodium Chloride 0.9% - Hypogonadism, Metabolic Syndrome X | Phase 3 | Completed | University Hospital, Basel, Switzerland | 70 | 2016-01-01 | 2017-07-13 |
| Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents Resveratrol, Placebo - NAFLD, TYPE 2 DIABETES | Phase 2 / Phase 3 | Completed | University of Manitoba | 10 | 2015-08-01 | 2017-05-05 |
| Effects of IL-1 Beta on the HPA-axis in Obese Persons Anakinra - Metabolic Syndrome, Hypersecretion; Cortisol | Phase 3 | Completed | University Hospital, Basel, Switzerland | 76 | 2014-10-01 | 2016-08-23 |
| Treatment of Morbidly Obese Adolescent With a Duodena-jejunal Liner Duodena-jejunal liner - Obesity, Diabetes | Phase 3 | Completed | University Medical Centre Ljubljana | 22 | 2014-07-01 | 2020-07-10 |
| The Improvements of Dietary Supplement of Black Rice on Metabolic Syndrome Black rice, follow-up - Metabolic Syndrome X | Phase 2 / Phase 3 | Completed | Sun Yat-sen University | 101 | 2014-06-01 | 2015-04-03 |
| Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion Dapagliflozin, Placebo - Metabolic Syndrome X | Phase 2 / Phase 3 | Completed | University of Guadalajara | 24 | 2014-04-01 | 2020-10-28 |
| Effects of Flaxseed Supplementation in Metabolic Syndrome flaxseed, lifestyle modification - Metabolic Syndrome | Phase 2 / Phase 3 | Completed | National Nutrition and Food Technology Institute | 44 | 2014-02-01 | 2015-07-14 |
| Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome Metformin Hydrochloride 850 MG Oral Tablet [Glucophage], Ludipress, mg stereate, micronized hydrated silica, talcum - Metabolic Syndrome | Phase 3 | Completed | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1600 | 2014-02-01 | 2021-09-28 |
| Study to Evaluate Safety and Efficacy of PreCrea® on Subjects With Higher Than Normal Blood Sugar Levels Study dietary supplement (PreCrea 600 mg capsules), Placebo - Diabetes Mellitus, Pre-Diabetes | Phase 3 | Completed | Joe Fenn | 210 | 2013-11-01 | 2015-05-18 |
| Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis Docosahexaenoic Acid plus Vitamin E plus choline, placebo pearls - Fatty Liver, Liver Fibrosis | Phase 3 | Completed | Bambino Gesù Hospital and Research Institute | 60 | 2013-10-01 | 2016-01-14 |
| Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study Ezetimibe, Placebo - Metabolic Syndrome X | Phase 3 | Completed | Laval University | 20 | 2013-06-01 | 2016-04-12 |
| Cardiovascular Inflammation Reduction Trial Methotrexate, Placebo - Cardiovascular Disease | Phase 3 | Completed | Brigham and Women's Hospital | 4786 | 2013-04-01 | 2020-07-24 |
Showing 20 of 73. Sign in to see all of them.
Obesity (14) · Diabetes Mellitus, Type 2 (8) · Hypertension (6) · Inflammation (6) · Insulin Resistance (6) · Dyslipidemias (5) · Glucose Intolerance (5) · Hyperglycemia (5) · Overweight (5) · Diabetes Mellitus (4) · Hypercholesterolemia (3) · Schizophrenia (3) · Hypertriglyceridemia (2) · Liver Cirrhosis (2)
Glucose Metabolism Disorders (73) · Hyperinsulinism (73) · Metabolic Diseases (73) · Nutritional and Metabolic Diseases (73) · Insulin Resistance (67) · Pathological Conditions, Signs and Symptoms (22) · Nutrition Disorders (17) · Overnutrition (17) · Signs and Symptoms (17) · Body Weight (16) · Endocrine System Diseases (16) · Overweight (12) · Pathologic Processes (11) · Diabetes Mellitus (10) · Lipid Metabolism Disorders (10)
Metformin (4) · Rosuvastatin Calcium (3) · Telmisartan (3) · salicylsalicylic acid (3) · Atorvastatin (2) · Berberine (2) · Genistein (2) · Interleukin 1 Receptor Antagonist Protein (2) · Linseed Oil (2) · Olmesartan Medoxomil (2) · Acarbose (1) · Aloe vera gel (1) · Amlodipine (1) · Antipsychotic Agents (1) · Arginine (1)
AstraZeneca (3) · Chinese Academy of Sciences (3) · Joslin Diabetes Center (3) · National Nutrition and Food Technology Institute (3) · University of Erlangen-Nürnberg Medical School (3) · Brigham and Women's Hospital (2) · Centro Universitario de Ciencias de la Salud, Mexico (2) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (2) · GWT-TUD GmbH (2) · University Hospital, Basel, Switzerland (2) · University of Guadalajara (2) · University of Messina (2) · University of Saskatchewan (2) · 5 Santé (1) · Ain Shams University (1)
United States (12) · Germany (9) · Canada (7) · Italy (7) · China (5) · Mexico (5) · Denmark (4) · France (3) · Spain (3) · Switzerland (3) · Australia (2) · Brazil (2) · Sweden (2) · Taiwan (2) · United Kingdom (2)
Allison B. Goldfine, MD (3) · Xu Lin, MD, PhD (3) · Francesco Squadrito, MD (2) · Kathleen Jablonski, PhD (2) · Myrlene Staten, MD (2) · Philip D Chilibeck, PhD (2) · Steven E. Shoelson, MD, PhD (2) · Vivian Fonseca, MD (2) · Angel Brea, MD (1) · Arya M Sharma, MD, FRCPC (1) · Brandy A Wicklow, MD, MSc (1) · Bruno Geloneze, PhD (1) · Eduardo Cabrera-Rode, PhD (1)
PMID 20826632, PMID 32275191, PMID 16636217, PMID 17416370, PMID 18509206, PMID 19156626, PMID 19321570, PMID 20231565, PMID 20484482, PMID 20573639, PMID 21164548, PMID 21270268, PMID 21795429, PMID 22082239, PMID 22090469, PMID 22108151, PMID 22170727, PMID 22215178, PMID 23404948, PMID 23731019, PMID 23817699, PMID 23895801, PMID 23899172, PMID 24130358, PMID 24171779, PMID 24371832, PMID 24401727, PMID 24462043, PMID 24947878, PMID 25001274, PMID 25084280, PMID 25140396, PMID 25816050, PMID 26001844, PMID 26336957, PMID 26385052, PMID 27302672, PMID 27306560, PMID 27438317, PMID 27717222, PMID 28031749, PMID 28106245, PMID 28260235, PMID 28324042, PMID 28673265, PMID 28740367, PMID 28962047, PMID 29052766, PMID 29065923, PMID 29268712
2005 (2), U01DK074556 (2), F32DK068902 (1), P50HL083813 (1), R01AG018198 (1), R01AG020076 (1), R01HL089474 (1), R01HL130296 (1), U01HL087072 (1), U01HL101389 (1), U01HL101422 (1)